Industry: Chemical & Material
Published Date: 2024-04-07
Pages: 89 Pages
Report ld: 2821521
Request Sample
Customized Report
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
The global Ivermectin API market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
In terms of production side, this report researches the Ivermectin API production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Ivermectin API by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Ivermectin API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Ivermectin API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Ivermectin API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ivermectin API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Ivermectin API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Ivermectin API sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Ivermectin API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Ivermectin API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Ivermectin API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ivermectin API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Ivermectin API Product Introduction
1.2 Market by Type
1.2.1 Global Ivermectin API Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Purity 98%
1.2.3 Purity 99%
1.3 Market by Application
1.3.1 Global Ivermectin API Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Research Organization
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Ivermectin API Production
2.1 Global Ivermectin API Production Capacity (2019-2030)
2.2 Global Ivermectin API Production by Region: 2019 VS 2023 VS 2030
2.3 Global Ivermectin API Production by Region
2.3.1 Global Ivermectin API Historic Production by Region (2019-2024)
2.3.2 Global Ivermectin API Forecasted Production by Region (2025-2030)
2.3.3 Global Ivermectin API Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Ivermectin API Revenue Estimates and Forecasts 2019-2030
3.2 Global Ivermectin API Revenue by Region
3.2.1 Global Ivermectin API Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Ivermectin API Revenue by Region (2019-2024)
3.2.3 Global Ivermectin API Revenue by Region (2025-2030)
3.2.4 Global Ivermectin API Revenue Market Share by Region (2019-2030)
3.3 Global Ivermectin API Sales Estimates and Forecasts 2019-2030
3.4 Global Ivermectin API Sales by Region
3.4.1 Global Ivermectin API Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Ivermectin API Sales by Region (2019-2024)
3.4.3 Global Ivermectin API Sales by Region (2025-2030)
3.4.4 Global Ivermectin API Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Ivermectin API Sales by Manufacturers
4.1.1 Global Ivermectin API Sales by Manufacturers (2019-2024)
4.1.2 Global Ivermectin API Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ivermectin API in 2023
4.2 Global Ivermectin API Revenue by Manufacturers
4.2.1 Global Ivermectin API Revenue by Manufacturers (2019-2024)
4.2.2 Global Ivermectin API Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Ivermectin API Revenue in 2023
4.3 Global Ivermectin API Sales Price by Manufacturers
4.4 Global Key Players of Ivermectin API, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Ivermectin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Ivermectin API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Ivermectin API, Product Offered and Application
4.8 Global Key Manufacturers of Ivermectin API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Ivermectin API Sales by Type
5.1.1 Global Ivermectin API Historical Sales by Type (2019-2024)
5.1.2 Global Ivermectin API Forecasted Sales by Type (2025-2030)
5.1.3 Global Ivermectin API Sales Market Share by Type (2019-2030)
5.2 Global Ivermectin API Revenue by Type
5.2.1 Global Ivermectin API Historical Revenue by Type (2019-2024)
5.2.2 Global Ivermectin API Forecasted Revenue by Type (2025-2030)
5.2.3 Global Ivermectin API Revenue Market Share by Type (2019-2030)
5.3 Global Ivermectin API Price by Type
5.3.1 Global Ivermectin API Price by Type (2019-2024)
5.3.2 Global Ivermectin API Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Ivermectin API Sales by Application
6.1.1 Global Ivermectin API Historical Sales by Application (2019-2024)
6.1.2 Global Ivermectin API Forecasted Sales by Application (2025-2030)
6.1.3 Global Ivermectin API Sales Market Share by Application (2019-2030)
6.2 Global Ivermectin API Revenue by Application
6.2.1 Global Ivermectin API Historical Revenue by Application (2019-2024)
6.2.2 Global Ivermectin API Forecasted Revenue by Application (2025-2030)
6.2.3 Global Ivermectin API Revenue Market Share by Application (2019-2030)
6.3 Global Ivermectin API Price by Application
6.3.1 Global Ivermectin API Price by Application (2019-2024)
6.3.2 Global Ivermectin API Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Ivermectin API Market Size by Type
7.1.1 US & Canada Ivermectin API Sales by Type (2019-2030)
7.1.2 US & Canada Ivermectin API Revenue by Type (2019-2030)
7.2 US & Canada Ivermectin API Market Size by Application
7.2.1 US & Canada Ivermectin API Sales by Application (2019-2030)
7.2.2 US & Canada Ivermectin API Revenue by Application (2019-2030)
7.3 US & Canada Ivermectin API Sales by Country
7.3.1 US & Canada Ivermectin API Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Ivermectin API Sales by Country (2019-2030)
7.3.3 US & Canada Ivermectin API Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Ivermectin API Market Size by Type
8.1.1 Europe Ivermectin API Sales by Type (2019-2030)
8.1.2 Europe Ivermectin API Revenue by Type (2019-2030)
8.2 Europe Ivermectin API Market Size by Application
8.2.1 Europe Ivermectin API Sales by Application (2019-2030)
8.2.2 Europe Ivermectin API Revenue by Application (2019-2030)
8.3 Europe Ivermectin API Sales by Country
8.3.1 Europe Ivermectin API Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Ivermectin API Sales by Country (2019-2030)
8.3.3 Europe Ivermectin API Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Ivermectin API Market Size by Type
9.1.1 China Ivermectin API Sales by Type (2019-2030)
9.1.2 China Ivermectin API Revenue by Type (2019-2030)
9.2 China Ivermectin API Market Size by Application
9.2.1 China Ivermectin API Sales by Application (2019-2030)
9.2.2 China Ivermectin API Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Ivermectin API Market Size by Type
10.1.1 Asia Ivermectin API Sales by Type (2019-2030)
10.1.2 Asia Ivermectin API Revenue by Type (2019-2030)
10.2 Asia Ivermectin API Market Size by Application
10.2.1 Asia Ivermectin API Sales by Application (2019-2030)
10.2.2 Asia Ivermectin API Revenue by Application (2019-2030)
10.3 Asia Ivermectin API Sales by Region
10.3.1 Asia Ivermectin API Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Ivermectin API Revenue by Region (2019-2030)
10.3.3 Asia Ivermectin API Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Ivermectin API Market Size by Type
11.1.1 Middle East, Africa and Latin America Ivermectin API Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Ivermectin API Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Ivermectin API Market Size by Application
11.2.1 Middle East, Africa and Latin America Ivermectin API Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Ivermectin API Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Ivermectin API Sales by Country
11.3.1 Middle East, Africa and Latin America Ivermectin API Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Ivermectin API Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Ivermectin API Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Tecoland
12.1.1 Tecoland Company Information
12.1.2 Tecoland Overview
12.1.3 Tecoland Ivermectin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Tecoland Ivermectin API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Tecoland Recent Developments
12.2 Merck & Co
12.2.1 Merck & Co Company Information
12.2.2 Merck & Co Overview
12.2.3 Merck & Co Ivermectin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Merck & Co Ivermectin API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Merck & Co Recent Developments
12.3 Samex Overseas
12.3.1 Samex Overseas Company Information
12.3.2 Samex Overseas Overview
12.3.3 Samex Overseas Ivermectin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Samex Overseas Ivermectin API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Samex Overseas Recent Developments
12.4 Hovione
12.4.1 Hovione Company Information
12.4.2 Hovione Overview
12.4.3 Hovione Ivermectin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Hovione Ivermectin API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hovione Recent Developments
12.5 Hangzhou Think Chemical
12.5.1 Hangzhou Think Chemical Company Information
12.5.2 Hangzhou Think Chemical Overview
12.5.3 Hangzhou Think Chemical Ivermectin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Hangzhou Think Chemical Ivermectin API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Hangzhou Think Chemical Recent Developments
12.6 Shandong Qilu King-Phar Pharmaceutical
12.6.1 Shandong Qilu King-Phar Pharmaceutical Company Information
12.6.2 Shandong Qilu King-Phar Pharmaceutical Overview
12.6.3 Shandong Qilu King-Phar Pharmaceutical Ivermectin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Shandong Qilu King-Phar Pharmaceutical Ivermectin API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Shandong Qilu King-Phar Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Ivermectin API Industry Chain Analysis
13.2 Ivermectin API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Ivermectin API Production Mode & Process
13.4 Ivermectin API Sales and Marketing
13.4.1 Ivermectin API Sales Channels
13.4.2 Ivermectin API Distributors
13.5 Ivermectin API Customers
14 Ivermectin API Market Dynamics
14.1 Ivermectin API Industry Trends
14.2 Ivermectin API Market Drivers
14.3 Ivermectin API Market Challenges
14.4 Ivermectin API Market Restraints
15 Key Finding in The Global Ivermectin API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Ivermectin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 131
USD 3950.00
(Single User License)
The global Ivermectin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 131
USD 2900.00
(Single User License)
The global Ivermectin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 131
USD 4900.00
(Single User License)
The global market for Ivermectin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 109
USD 3950.00
(Single User License)
The global market for Ivermectin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 89
USD 2900.00
(Single User License)
The global Ivermectin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 76
USD 4250.00
(Single User License)
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published Date: 2024-02-19
Pages: 98
USD 3950.00
(Single User License)
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published Date: 2024-01-11
Pages: 93
USD 2900.00
(Single User License)
The global market for Ivermectin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 131
The global Ivermectin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 131
The global Ivermectin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 131
The global market for Ivermectin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 109
The global market for Ivermectin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 89
The global Ivermectin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 76
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published: 2024-02-19
Pages: 98
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published: 2024-01-11
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now